We have read the excellent article by de Lemos et al 1 on the prognostic significance of the monocyte chemoattractant protein-1 (MCP-1) in the long-term clinical outcomes in patients with acute coronary syndromes. Because MCP-1 has been shown to be related to atherosclerosis development, 2 we measured the concentration of this chemokine in blood drawn from the coronary sinus in a small sample of unstable angina patients (nϭ24). All of them had an ejection fraction Ͼ50% and no history of current inflammatory diseases, recent (3 months) myocardial necrosis, coronary angioplasty, or bypass surgery (1 year). Coronary angiograms were evaluated separately and blindly by 2 cardiologists, and a score of severity was created by totaling points (0, normal; 1, minimal to 30% stenosis; 2, 50% stenosis; 3, 70% to 90% stenosis; and 4, total occlusion) at 29 predefined arterial segments according to the Bypass Angioplasty Revascularization Investigation (BARI). 3 The range of scores was 1 to 29 points (12.3Ϯ7.4 points [meanϮSD]). The values of MCP-1 were between 6.7 and 367.1 pg/mL (124.0Ϯ7.4 pg/mL). A Pearson significant correlation was found between the score of coronary disease and MCP-1 (Rϭ0.783; PϽ0.001). Furthermore, a multiple regression with the score of coronary disease severity as outcome (dependent variable) showed a ␤ coefficient for MCP-1 of 0.062 (95% CI, 0.034 -0.091; PϽ0.001) after adjustment for age, gender, arterial hypertension, hypercholesterolemia, diabetes, current smoking, body mass index, and ratio of total cholesterol to high-density lipoprotein cholesterol. The R 2 was 0.789 for the fully adjusted multiple regression model.
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To the Editor:
We have read the excellent article by de Lemos et al 1 on the prognostic significance of the monocyte chemoattractant protein-1 (MCP-1) in the long-term clinical outcomes in patients with acute coronary syndromes. Because MCP-1 has been shown to be related to atherosclerosis development, 2 we measured the concentration of this chemokine in blood drawn from the coronary sinus in a small sample of unstable angina patients (nϭ24). All of them had an ejection fraction Ͼ50% and no history of current inflammatory diseases, recent (3 months) myocardial necrosis, coronary angioplasty, or bypass surgery (1 year). Coronary angiograms were evaluated separately and blindly by 2 cardiologists, and a score of severity was created by totaling points (0, normal; 1, minimal to 30% stenosis; 2, 50% stenosis; 3, 70% to 90% stenosis; and 4, total occlusion) at 29 predefined arterial segments according to the Bypass Angioplasty Revascularization Investigation (BARI). 3 The range of scores was 1 to 29 points (12.3Ϯ7.4 points [meanϮSD]). The values of MCP-1 were between 6.7 and 367.1 pg/mL (124.0Ϯ7.4 pg/mL). A Pearson significant correlation was found between the score of coronary disease and MCP-1 (Rϭ0.783; PϽ0.001). Furthermore, a multiple regression with the score of coronary disease severity as outcome (dependent variable) showed a ␤ coefficient for MCP-1 of 0.062 (95% CI, 0.034 -0.091; PϽ0.001) after adjustment for age, gender, arterial hypertension, hypercholesterolemia, diabetes, current smoking, body mass index, and ratio of total cholesterol to high-density lipoprotein cholesterol. The R 2 was 0.789 for the fully adjusted multiple regression model.
MCP-1 concentration in coronary sinus venous blood is likely to reflect precisely what is happening in the coronary wall. Our finding suggests that coronary disease severity depends in part on MCP-1 production by cells in the coronary atheromas. Therefore, we think that this association may help to explain the prognostic significance of MCP-1 concentration in peripheral blood reported by de Lemos et al. 1
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